WeVote

Bill

Bill

SB 6019

Expanding prescriptive authority for pharmacists.

2023-2024 Regular Session Introduced by John Braun and 3 co-sponsors

Washington bill expands pharmacist prescribing authority for routine medications to improve healthcare access and address provider shortages, raising concerns about safety oversight and physician opposition.

First reading, referred to Health & Long Term Care.
0
WeVote Research Nonpartisan
Bill Summary · SB 6019

Legislative bill overview

SB 6019 expands the prescriptive authority of licensed pharmacists in Washington state, allowing them to initiate and manage certain medications without requiring a physician's prescription. The bill broadens pharmacists' clinical responsibilities within defined scope parameters to address healthcare access gaps and workforce shortages.

Why is this important

Pharmacists are often the most accessible healthcare providers in many communities, and expanded prescriptive authority could improve medication access for routine conditions, reduce emergency department visits, and help offset physician shortages. However, this represents a meaningful shift in the traditional prescriber-pharmacist relationship and medication safety oversight structures.

Potential points of contention

  • Scope of authority limitations: Questions about which specific medications, conditions, and patient populations pharmacists could treat, and whether the boundaries are appropriately defined or too broad
  • Patient safety and liability: Concerns from medical boards about diagnostic accuracy, drug interaction management, and who bears responsibility if medication errors occur
  • Professional turf conflicts: Resistance from physician organizations who view this as encroachment on medical practice, versus support from healthcare access advocates
  • Insurance and reimbursement: Uncertainty about whether insurance plans will reimburse pharmacist-initiated treatment and at what rates

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.